This inventor holds 31 USPTO granted patents and 1 EPO patent, primarily in Antibody Production. Top assignees: Unilever Patent Holdings B.v., Lever Brothers Company, Division of Conopco, Inc., Bac IP B.v.. Active years: 1976-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Maasslius, NL (1993)
- Maassluis, NL (1976 - 2005)
- KB Maassluis, NL (2010)
- Vlaardingen, NL (2000 - 2015)
Company Filing History:



Years Active: 1976-2015
Areas of Expertise:
Title: **Cornelis T. Verrips: Innovator in Biotechnology**
Introduction
Cornelis T. Verrips, based in Maassluis, Netherlands, is a notable inventor with an impressive portfolio of 31 patents. His contributions to the field of biotechnology have significantly advanced the understanding and application of antibodies in various products, showcasing his expertise in the intersection of microbiology and immunology.
Latest Patents
Among his latest patents are groundbreaking innovations involving products that incorporate inactivated yeasts or moulds alongside active VHH-type antibodies. This technology aims to enhance the stability of antibody specificity under destabilizing conditions that typically inactivate traditional eukaryotes and antibodies. Such advancements exhibit Cornelis' commitment to pioneering solutions that address challenges in biological product development.
Career Highlights
Throughout his career, Cornelis has made significant contributions while working with prominent companies, including Unilever Patent Holdings B.V. and Lever Brothers Company, a division of Conopco, Inc. His tenure at these organizations allowed him to apply his innovative thinking in real-world scenarios, thus enhancing the efficacy and stability of biotechnology products.
Collaborations
Collaboration has been a key aspect of Cornelis' career. He has worked alongside esteemed colleagues such as Adrianus M. Ledeboer and Daniel Convents. These partnerships have fostered a collaborative environment that has been instrumental in driving forward research and innovation in his field.
Conclusion
In conclusion, Cornelis T. Verrips stands out as a significant figure in biotechnology, evidenced by his extensive patent portfolio and collaborations with notable industry professionals. His work continues to influence and inspire advancements in biotechnology, making him a pivotal inventor in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile